RAB Insights

RAB Research Archive

6 Facts About Obesity and Weight Loss Drugs in the U.S.



About half of U.S. adults say they hear or read about popular weight-loss drugs like Ozempic and Wegovy very or extremely often, reflecting how these medications have moved into mainstream public awareness alongside rising obesity rates.

This widespread visibility signals a shift in health-related consumer conversations and lifestyle priorities that brands can tap into by aligning messaging with wellness trends, affordability concerns, and evolving attitudes toward weight management.

Source: Pew Research Center



View / Download Share